RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien
Razi Ingber, RedHill Biopharma and Chief Financial Officer, said: “We [...]
Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease
This landmark project will focus on the opportunity for AI [...]
Addex Therapeutics to Present at the Thirteenth London International Cough Symposium (13th LICS)
Mikhail Kalinichev, Head of Translational Science, will present at the [...]
Medsenic, a Subsidiary of BioSenic SA, Extends Key Patent to the United States
Medsenic SAS, subsidiary of BioSenic SA, is exploring the therapeutic [...]
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ ®
IXCHIQ ® is the world’s only licensed chikungunya vaccine available [...]
Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research
“CTCs are rare — as low as only 1–10 can [...]
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera
“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases [...]
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001
Sterling Chung, Vice President of Regulatory Affairs and Quality at [...]
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor [...]
Sphere Fluidics Awarded Gold Accreditation by Investors in People
Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in [...]